Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice
IntroductionEvaluation of every breast cancer (BC) patient by multidisciplinary team and application of guidelines are very important to ensure the best treatment and achieve the best outcome.MethodsThe multicenter prospective observational BRIDE study enrolled, from 01/2018 to 02/2021, 1633 BC pati...
Saved in:
| Main Authors: | Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Gianluigi Ferretti, Elisabetta Cretella, Lorenzo Gianni, Claudia Bighin, Angela Toss, Claudio Zamagni, Patrizia Vici, Costanza De Rossi, Antonio Russo, Giancarlo Bisagni, Alessio Schirone, Lucia Borgato, Anna Cariello, Claudia Cappelletti, Roberto Bordonaro, Saverio Cinieri, Alessandra Modena, Matteo Valerio, Maria Francesca Alvisi, Irene De Simone, Francesca Galli, Eliana Rulli, Anna Santoni, Matteo Verzè, Fabrizio Nicolis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1501667/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dare un nome ai cani (Prospero, Alonso, Atteone)
by: Piermario Vescovo
Published: (2025-02-01) -
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment Pathway
by: Stefania Gori, et al.
Published: (2025-05-01) -
Ambulatory oral surgeries are safe procedures for medically compromised older people patients: a retrospective study
by: Pippi Roberto, et al.
Published: (2025-01-01) -
Enhancing Defect Detection on Surfaces Using Transfer Learning and Acoustic Non-Destructive Testing
by: Michele Lo Giudice, et al.
Published: (2025-06-01) -
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
by: Stefania Gori, et al.
Published: (2016-01-01)